References
- Kumar A, Juluru K, Thimmaraju P, Reddy J, Patil A. Pharmaceutical market access in emerging markets: Concepts, components, and future. J Mark Access Health Policy. 2014; 2 25302, doi: http://dx.doi.org/10.3402/jmahp.v2.25302 .
- Eichler HG, Pignatti F, Flamion B, Leufkens H, Breckenridge A. Balancing early market access to new drugs with the need for benefit/risk data: A mounting dilemma. Nat Rev Drug Discov. 2008; 7: 818–26.
- Thompson RB. Foundations for blockbuster drugs in federally sponsored research. FASEB J. 2001; 15: 1671–6.
- Gottlieb S. Drug companies maintain ‘astounding’ profits. BMJ. 2002; 324: 1054.
- Qattan M, Demonacos C, Krstic-Demonacos M. Roadmap to personalized medicine. Croat Med J. 2012; 53: 294–7.
- Odeyemi I. Demystifying pharmaceutical market access. 2014; Paris, France: European Market Access University Diploma.
- Robinson S. Market access-the definition depends on the viewpoint. Evidence Matters. 2010; 16 1–2..
- Wight C. The true meaning of market access? Understanding fully the words that define market access is the first step on the route to success. 2012. Available at: http://www.pmlive.com/pharma_intelligence/the_true_meaning_of_market_access_422511 .
- Eichler HG, Bloechl-Daum B, Abadie E, Barnett D, Konig F, Pearson S. Relative efficacy of drugs: An emerging issue between regulatory agencies and third-party payers. Nat Rev Drug Discov. 2010; 9: 277–91.
- Odeyemi I. Developing a pharmaceutical market access strategy: The KIPs framework. 2014; Paris, France: European Market Access University Diploma.
- Jonsson B, Wilking N. Cancer vaccines and immunotherapeutics: Challenges for pricing, reimbursement and market access. Hum Vaccin Immunother. 2012; 8: 1360–3.
- Payne K, Annemans L. Reflections on market access for personalized medicine: Recommendations for Europe. Value Health. 2013; 16(Suppl 6): S32–8.
- Rofail D, Taylor F, Regnault A, Filonenko A. Treatment satisfaction instruments for different purposes during a product's lifecycle: Keeping the end in mind. Patient. 2011; 4: 227–40.